75 related articles for article (PubMed ID: 21251952)
1. HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death.
Limami Y; Pinon A; Leger DY; Mousseau Y; Cook-Moreau J; Beneytout JL; Delage C; Liagre B; Simon A
Biochimie; 2011 Apr; 93(4):749-57. PubMed ID: 21251952
[TBL] [Abstract][Full Text] [Related]
2. The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells.
Limami Y; Pinon A; Leger DY; Pinault E; Delage C; Beneytout JL; Simon A; Liagre B
Biochimie; 2012 Aug; 94(8):1754-63. PubMed ID: 22521508
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
7. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
8. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
[TBL] [Abstract][Full Text] [Related]
9. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
10. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
[TBL] [Abstract][Full Text] [Related]
11. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q
Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism of cyclooxygenase-2 inhibitor in inhibition of proliferation of colon cancer cells by modulating Stat5 signal transduction pathway].
Ma XT; Yu LW; Wang S; Zhang H; Du RY; Cui ZR
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2566-9. PubMed ID: 16321305
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.
Onoda T; Ono T; Dhar DK; Yamanoi A; Fujii T; Nagasue N
J Lab Clin Med; 2004 Apr; 143(4):207-16. PubMed ID: 15085079
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
15. The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells.
Chien CC; Ko CH; Shen SC; Yang LY; Chen YC
J Cell Physiol; 2012 Aug; 227(8):3128-37. PubMed ID: 22170686
[TBL] [Abstract][Full Text] [Related]
16. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
17. [Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
Réti A
Magy Onkol; 2010 Dec; 54(4):377-81. PubMed ID: 21163769
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway.
Zhang YJ; Bao YJ; Dai Q; Yang WY; Cheng P; Zhu LM; Wang BJ; Jiang FH
Ann Surg Oncol; 2011 Feb; 18(2):580-8. PubMed ID: 20803081
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
Leung E; McArthur D; Morris A; Williams N
Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
